共 50 条
- [41] Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
- [43] Prospective evaluation of migraine premonitory symptoms during the 30 days period [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
- [45] The premonitory phase of migraine and migraine management [J]. CEPHALALGIA, 2013, 33 (13) : 1117 - 1121
- [48] Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine [J]. The Journal of Headache and Pain, 2021, 22